CALCOBUTROL SODIUM

Details

Stereochemistry	RACEMIC
Molecular Formula	C18H31N4O9.Ca.Na
Molecular Weight	510.528
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Na+].[Ca++].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1

InChI

InChIKey=YZRJMLDIJKMCBB-FXUMYAARSA-K

InChI=1S/C18H34N4O9.Ca.Na/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);;/q;+2;+1/p-3/t14-,15-;;/m1../s1

HIDE SMILES / InChI

Description
Sources: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201277Orig1s000ChemR.pdf | https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19910925&CC=EP&NR=0448191A1&KC=A1 | https://www.ncbi.nlm.nih.gov/pubmed/11670244 | https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201277Orig1s000ChemR.pdf

Calcobutrol, is a new macrocyclic polyhydroxylated gadolinium chelate derivative which can be used as a contrast agent for Magnetic Resonance Imaging (MRI) and component of Gadavist. Gadavist is a gadolinium-based contrast agent indicated for intravenous use in diagnostic MRI in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system

Originator

Approval Year

PubMed

Title	Date	PubMed
Synthesis and Structure of a New Macrocyclic Polyhydroxylated Gadolinium Chelate Used as a Contrast Agent for Magnetic Resonance Imaging.	1997-12-17	11670244

Patents

Name

Type

Language

CALCOBUTROL SODIUM

Common Name

English

CALCIUM SODIUM BUTROL

Preferred Name

English

1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, 10-(2,3-DIHYDROXY-1-(HYDROXYMETHYL)PROPYL)-, CALCIUM, SODIUM SALT (1:1), (R*,S*)-(±)-

Systematic Name

English

Code System Code Type Description

FDA UNII

PO5286589K